Industry News
Drug Eluting Stent
14/07/08
Drug Eluting Stent
Abbott announced the start of a post-approval study, with six hospital centers already recruiting and enrolling patients just one week after the U.S. Food and Drug Administration approved the XIENCE VT Everolimus Eluting Coronary Stent System. The study will evaluate the safety and effectiveness of the drug eluting stent in a real-world clinical setting out to five years. Jack Jones, M.D., interventional cardiologist and medical director of the Stormont-Vail Catheterization Lab in Topeka, Kansas, was one of the first physicians to enrol a patient into the study.
Pingbacks:
No Pingbacks for this post yet...
Industry News
The healthcare industry is an ever-changing, ever-adapting environment. MET can help you ensure you are kept up to date by providing you with the latest industry news.
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| << < | > >> | |||||
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
Search
Categories
- All
- Alerts (4)
- Announcements (48)
- Awards (3)
- Breakthroughs (11)
- Clinical Trials (8)
- Diagnostics (2)
- Guidelines (30)
- Mergers (7)
- New Devices (16)
- Procedures (5)
- Published Articles (2)
- Regulations (14)
- Reviews (2)
- Standards (78)
- Takeovers (1)
Archives
- August 2008 (23)
- July 2008 (8)
- June 2008 (41)
- May 2008 (20)
- April 2008 (33)
- March 2008 (10)
- February 2008 (38)
- January 2008 (25)
- December 2007 (22)
- November 2007 (9)
- More...
Misc
XML Feeds
What is RSS?
Who's Online?
- Guest Users: 6
